Drugs That Distort Total Testosterone Test Results

What Total Testosterone Actually Measures

Total testosterone is the sum of three circulating fractions: testosterone tightly bound to sex hormone-binding globulin (SHBG, roughly 65%), testosterone loosely bound to albumin (about 33%), and unbound "free" testosterone (1 to 3%). A standard immunoassay or liquid chromatography-tandem mass spectrometry (LC-MS/MS) measurement captures all three fractions in a single number, reported in ng/dL or nmol/L 1.

That single number is deceptively simple. Any drug that changes SHBG concentration, suppresses the hypothalamic-pituitary-gonadal (HPG) axis, or interferes with the laboratory assay chemistry will shift the result. Two men with identical free testosterone can have total testosterone values 300 ng/dL apart if one takes a medication that doubles his SHBG. The Endocrine Society's 2018 guideline explicitly recommends measuring both total and free testosterone when SHBG-altering medications are present 1.

LC-MS/MS is the gold-standard method and resists most chemical interferences. Immunoassays, still used in many commercial labs, are vulnerable to cross-reactivity with synthetic steroids and to biotin-streptavidin binding artifacts 2.

Drugs That Falsely Lower Total Testosterone

Several widely prescribed medication classes suppress the HPG axis or directly impair Leydig cell steroidogenesis, producing genuinely low total testosterone readings that reflect drug-induced hypogonadism rather than a primary endocrine disorder.

Opioids. Chronic opioid therapy is the most common pharmacologic cause of acquired hypogonadism in men under 60. A 2014 systematic review found that 69% of men on long-term opioids had total testosterone below 300 ng/dL 3. The mechanism is central: opioids suppress GnRH pulsatility, dropping LH and FSH. Even short-acting formulations taken around the clock (oxycodone, hydrocodone) produce this effect within two to four weeks. Methadone and extended-release morphine carry the highest risk in comparative analyses 3.

Glucocorticoids. Prednisone, dexamethasone, and hydrocortisone suppress both CRH/ACTH and GnRH secretion. Doses equivalent to 7.5 mg/day of prednisone or higher reliably reduce total testosterone by 30 to 50% 4. Even inhaled corticosteroids at high doses (fluticasone 1 to 000 mcg/day) have been associated with lower morning testosterone in some cohorts 4.

GnRH agonists and antagonists. Leuprolide, goserelin, and degarelix are designed to suppress testosterone to castrate levels (below 50 ng/dL) for prostate cancer treatment. These drugs will produce profoundly low total testosterone readings. The clinical context usually makes this obvious, but patients sometimes present for unrelated lab work without disclosing their oncology medications 5.

Ketoconazole. Oral ketoconazole directly inhibits CYP17A1 and CYP11A1, the enzymes that synthesize testosterone in the testes and adrenal glands. At doses of 400 mg/day or higher, total testosterone can fall below 150 ng/dL within 24 to 48 hours 6. Topical ketoconazole shampoo does not produce systemic levels sufficient to affect the test.

Spironolactone. This mineralocorticoid receptor antagonist also blocks the androgen receptor and inhibits 17-alpha-hydroxylase. At typical doses for acne or heart failure (25 to 100 mg/day), total testosterone may drop modestly. At the 200 mg/day doses used in transgender feminizing regimens, suppression is more pronounced 7.

Drugs That Falsely Raise Total Testosterone

A result above the reference range does not always mean endogenous overproduction. Exogenous androgens and HPG-axis stimulators are common culprits.

Exogenous testosterone. Testosterone cypionate, enanthate, undecanoate, gels, patches, and pellets will raise total testosterone, often to supraphysiologic levels of 1 to 200 ng/dL or higher at peak absorption. The Endocrine Society recommends measuring trough levels (drawn the morning before the next injection for cypionate/enanthate) to avoid misinterpreting a peak-level sample 1. Simultaneously suppressed LH and FSH (both typically below 1 mIU/mL) confirm exogenous source.

Anabolic-androgenic steroids. Nandrolone, stanozolol, oxandrolone, and other AAS may or may not cross-react with the testosterone immunoassay depending on structural similarity. Nandrolone and its metabolites show minimal cross-reactivity, so a user might paradoxically have normal-appearing total testosterone despite supraphysiologic androgen exposure, while LH and FSH are fully suppressed. LC-MS/MS methods are more specific and less susceptible to this artifact 2.

Clomiphene citrate. This selective estrogen receptor modulator blocks estrogen feedback at the hypothalamus, increasing GnRH and LH output. In hypogonadal men, clomiphene 25 to 50 mg/day raises total testosterone an average of 200 to 400%, from roughly 230 ng/dL to 580 ng/dL in published series 8. LH and FSH are elevated rather than suppressed, distinguishing this pattern from exogenous testosterone.

Human chorionic gonadotropin (hCG). Because hCG mimics LH, it directly stimulates Leydig cells to produce testosterone. Doses of 1,500 to 3 to 000 IU two to three times per week can raise total testosterone by 200 to 300 ng/dL 9. This is commonly co-prescribed with TRT to maintain intratesticular testosterone and fertility.

DHEA supplements. Over-the-counter dehydroepiandrosterone (25 to 100 mg/day) converts peripherally to testosterone and estradiol. In women, even 25 mg/day of DHEA can raise total testosterone above the female reference range. In men, the effect is smaller but can add 50 to 80 ng/dL to baseline readings 10.

Drugs That Shift SHBG and Distort the Total-to-Free Ratio

These medications do not necessarily change how much testosterone the body produces. They change how much gets bound to SHBG, altering total testosterone while leaving bioavailable testosterone relatively stable. This is the most clinically deceptive category because the total testosterone number moves without a proportional change in the hormone fraction that activates androgen receptors.

SHBG-raising drugs (total T appears higher than clinical effect): Oral estrogens (conjugated equine estrogens, ethinyl estradiol in combined oral contraceptives), tamoxifen, raloxifene, carbamazepine, phenytoin, phenobarbital, and levothyroxine at supraphysiologic doses all increase hepatic SHBG synthesis. Carbamazepine and phenytoin raise SHBG by 30 to 50% through hepatic enzyme induction 11. A patient on phenytoin might have a total testosterone of 500 ng/dL but a calculated free testosterone equivalent to someone with a total of 340 ng/dL.

SHBG-lowering drugs (total T appears lower than clinical effect): Insulin (endogenous hyperinsulinemia in metabolic syndrome), androgenic progestins (levonorgestrel, norgestrel), and high-dose glucocorticoids reduce SHBG. Metformin does not directly change SHBG but may raise it slightly by reducing insulin levels in insulin-resistant patients 12. Danazol, a synthetic androgen, suppresses SHBG substantially.

The practical takeaway: when a patient takes any SHBG-altering drug, ordering free testosterone (by equilibrium dialysis, not analog immunoassay) gives a far more accurate picture of androgen status than total testosterone alone 1.

Assay Interference: When the Chemistry Lies

Some substances do not change actual testosterone concentration in the blood. They fool the laboratory instrument.

Biotin. The FDA issued a safety communication in November 2017 warning that biotin (vitamin B7) at doses of 5 to 10 mg/day (common in hair and nail supplements) interferes with streptavidin-biotin immunoassays 13. Depending on assay design, biotin can cause falsely high or falsely low testosterone readings. Competitive immunoassays tend to produce falsely elevated results; sandwich immunoassays tend to produce falsely low results. The fix is simple: stop biotin at least 72 hours before the blood draw.

Heterophilic antibodies. Patients exposed to mouse-derived monoclonal antibodies (from certain imaging agents or biologic therapies) can develop human anti-mouse antibodies (HAMA) that bridge the capture and detection antibodies in an immunoassay, producing falsely elevated results. Reported prevalence is 1 to 5% in the general population, but higher in patients treated with murine-derived biologics 2.

Cross-reactivity with synthetic steroids. Older direct immunoassays for testosterone show variable cross-reactivity with methyltestosterone, danazol, and boldenone. LC-MS/MS eliminates this problem entirely and is recommended by the Endocrine Society for confirmatory testing 1.

How to Get an Accurate Total Testosterone Result

The 2018 Endocrine Society Clinical Practice Guideline recommends two morning (before 10:00 a.m.) fasting samples on separate days to confirm low testosterone before initiating therapy 1. Layering drug-awareness onto that protocol strengthens accuracy.

Before the draw, review the full medication list. Flag every drug in the categories above. Opioids, glucocorticoids, anticonvulsants, exogenous androgens, clomiphene, hCG, DHEA, and spironolactone all require documentation on the lab requisition so the interpreting clinician can contextualize the result.

Hold biotin. Stop all biotin-containing supplements at least 72 hours before the blood draw. Many multivitamins contain 30 to 100 mcg, which is unlikely to interfere, but standalone "hair, skin, and nail" supplements frequently contain 2,500 to 10 to 000 mcg (2.5 to 10 mg) 13.

Request LC-MS/MS when immunoassay results are discordant with clinical presentation. If total testosterone reads normal but the patient has clear signs of hypogonadism (or vice versa), repeat the test using mass spectrometry at a reference lab 2.

Order free testosterone by equilibrium dialysis whenever the patient takes an SHBG-altering medication. Calculated free testosterone using the Vermeulen equation is an acceptable alternative if equilibrium dialysis is unavailable, provided SHBG and albumin are also measured 14.

Time injections correctly. For testosterone cypionate or enanthate (weekly or biweekly dosing), draw the sample at trough, meaning the morning of the next scheduled injection. For daily gels or patches, draw two to four hours after application for peak monitoring, or before application for trough 1.

Quick-Reference Drug Interaction Table

Drugs that lower total testosterone (HPG suppression or direct inhibition): Opioids (morphine, oxycodone, methadone, buprenorphine at high doses), glucocorticoids (prednisone, dexamethasone, hydrocortisone), GnRH agonists (leuprolide, goserelin), GnRH antagonists (degarelix, relugolix), ketoconazole (oral), spironolactone, abiraterone, and enzalutamide.

Drugs that raise total testosterone (exogenous supply or HPG stimulation): Testosterone formulations (cypionate, enanthate, undecanoate, gels, patches, pellets), anabolic-androgenic steroids, clomiphene citrate, enclomiphene, hCG, anastrozole, letrozole, and DHEA.

Drugs that alter SHBG (distort total T relative to free T): SHBG increasers: oral estrogens, tamoxifen, raloxifene, carbamazepine, phenytoin, phenobarbital, levothyroxine (excess), mitotane. SHBG decreasers: insulin (hyperinsulinemia), danazol, androgenic progestins, high-dose glucocorticoids.

Assay interferents (affect the measurement, not the hormone): Biotin (5 mg/day or higher), heterophilic antibodies, and cross-reactive synthetic steroids on immunoassay platforms.

If a patient takes two or more drugs from different categories simultaneously, effects can compound unpredictably. A man on both methadone (suppresses production) and phenytoin (raises SHBG) might present with total testosterone of 180 ng/dL, a value far lower than either drug alone would produce 3 11.

The minimum workup in any patient on a known interfering medication: total testosterone by LC-MS/MS, free testosterone by equilibrium dialysis, SHBG, LH, and FSH, drawn fasting before 10:00 a.m. on two separate mornings 1.